James L. Cave - May 31, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
INTERIM CAO
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
May 31, 2024
Transactions value $
-$9,528
Form type
4
Date filed
6/4/2024, 04:05 PM
Previous filing
May 6, 2024
Next filing
Sep 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +339 +3.24% 10.8K May 31, 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1K +9.28% 11.8K May 31, 2024 Direct F1
transaction TDOC Common Stock Options Exercise +383 +3.25% 12.2K May 31, 2024 Direct F1
transaction TDOC Common Stock Options Exercise +1.16K +9.55% 13.3K May 31, 2024 Direct F1
transaction TDOC Common Stock Sale -$9.53K -854 -6.41% $11.16 12.5K Jun 3, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -339 -25% $0.00 1.02K May 31, 2024 Common Stock 339 Direct F1, F3
transaction TDOC Restricted Stock Units Options Exercise $0 -1K -100% $0.00* 0 May 31, 2024 Common Stock 1K Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -383 -19.98% $0.00 1.53K May 31, 2024 Common Stock 383 Direct F1, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -1.16K -12.49% $0.00 8.14K May 31, 2024 Common Stock 1.16K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3 On April 1, 2022, the reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F4 On June 1, 2022, the reporting person was granted 4,002 restricted stock units, vesting in four substantially equal semiannual installments beginning on the six-month anniversary of the grant date.
F5 On June 1, 2022, the reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F6 On March 3, 2023, the reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.